openPR Logo
Press release

Global Veterinary Vaccine Adjuvants Market to Reach USD 674.2 Million by 2034 rise at a CAGR of 4.6%, Driven by Rising Demand for Animal Health Solutions | FMI

01-29-2025 10:36 AM CET | Health & Medicine

Press release from: Future Market Insights Inc

Veterinary Vaccine Adjuvants Market

Veterinary Vaccine Adjuvants Market

The global veterinary vaccine adjuvants market is experiencing strong growth, with sales estimated to reach USD 431.4 million in 2024 and projected to grow to USD 674.2 million by 2034. This growth represents a compound annual growth rate (CAGR) of 4.6% over the forecast period. In 2023, the market generated USD 412.7 million in revenue, reflecting continued demand for advanced solutions in animal health and disease prevention.

The rapid expansion of the livestock and poultry sectors to meet increasing global food consumption is driving this market growth. As animal health becomes a more prominent concern worldwide, the demand for vaccines and adjuvants to prevent diseases has surged. Additionally, increasing awareness of zoonotic diseases-those that can be transmitted between animals and humans-is highlighting the importance of effective, high-quality vaccines. This shift in focus is encouraging the development of novel adjuvants that enhance the efficacy of vaccines, which is further fueling market demand.

Get Access to Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d3139383637

The rise in pet ownership and the growing focus on preventive care in the pet industry is another key factor supporting the expansion of veterinary vaccine adjuvants. Pet owners are increasingly seeking solutions to protect their animals from disease, which has led to a surge in research and development of adjuvants tailored to companion animals. This trend is expected to add significant momentum to the market in the coming years.

As the demand for vaccines and adjuvants grows, the industry is likely to see further innovation and investment in research to meet the needs of both livestock and companion animal sectors.

"The veterinary vaccine adjuvants market is poised for robust growth, driven by both the expanding agricultural sector and the increasing focus on pet health, the continuous advancements in adjuvant technology, aimed at enhancing vaccine effectiveness, will play a pivotal role in shaping the future of veterinary medicine." said opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Key Takeaways:
• The global veterinary vaccine adjuvants market was valued at USD 412.7 million in 2023.
• The market is expected to grow to USD 431.4 million in 2024.
• The market is projected to reach USD 674.2 million by 2034.
• The market is expected to grow at a 4.6% CAGR during the forecast period from 2024 to 2034.
• United States: Anticipated to exhibit a 2.6% Value CAGR from 2024 to 2034.
• China: Expected to show a strong 7.5% Value CAGR during the same period.
• Germany: Projected to grow at a 2.3% Value CAGR from 2024 to 2034.
• India: Expected to show the highest growth, with a 7.8% Value CAGR from 2024 to 2034.
• South Korea: Anticipated to grow at 7.1% Value CAGR during the forecast period.
• Mineral salts dominate the veterinary vaccine adjuvants market, holding a 53.7% market share.
• Livestock animals represent 70.1% of the market share and are expected to drive significant growth during the forecast period.

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report! https://www.globenewswire.com/news-release/2024/11/18/2982988/0/en/Global-Veterinary-Vaccine-Adjuvants-Market-to-Reach-USD-674-2-Million-by-2034-Driven-by-Rising-Demand-for-Animal-Health-Solutions-FMI.html

Competitive Landscape:
The veterinary vaccine adjuvants market is highly competitive, with key players focusing on innovation and expanding infrastructure to meet increasing industry demands. Companies are developing specialized adjuvants for different animal categories, enhancing vaccine effectiveness, and addressing emerging health concerns.

At the same time, significant investments in cutting-edge manufacturing facilities demonstrate a commitment to scaling production and ensuring a consistent supply of high-quality adjuvant ingredients. This competitive environment underscores a strategic focus on evolving customer needs and maintaining technological leadership in the sector.

Recent Industry Developments in the Veterinary Vaccine Adjuvants Market:
• In June 2023, Croda, Inc. announced the opening of a 23,680-square-foot facility dedicated to the production of ingredients for drug delivery systems.
• On April 29, 2020, Seppic launched MONTANIDE™ ISA 78 VG, an advanced adjuvant designed specifically for poultry vaccines. This innovative adjuvant boosts immune responses in poultry, addressing the growing demand for more effective vaccine solutions in the industry.

Key Players of Veterinary Vaccine Adjuvants Industry:
• SEPPIC (Air Liquide)
• Phibro Animal Health Corporation
• InvivoGen
• SPI Pharma (Associated British Foods Plc.)
• Croda International Plc
• Evonik Industries AG
• OZ Biosciences
• Creative Biogene
• Creative Biolabs
• Novavax
• Edinburgh Innovations
• Innaxon
• Merck & Co., Inc. (MSD Animal Health)

Key Segments of Veterinary Vaccine Adjuvants Industry:
By Technology:
In terms of technology, the industry is divided into mineral salt (aluminum salt, calcium phosphate), emulsions (oil-in-water (o/w) emulsions, water-in-oil (w/o) emulsions), saponins, toll-like receptor (TLR) agonists, cytokines, polymers (natural, synthetic), liposomes, other.

By Animal:
In terms of animal, the industry is divided into companion animals, livestock animals and aquaculture

By Vaccine Type:
In terms of vaccine type, the industry is divided into inactivated vaccines, subunit vaccines, toxoid vaccines and DNA vaccines

By Route of Administration:
In terms of route of administration, the industry is divided into oral route, mucosal, intramuscular, subcutaneous and others

By End User:
In terms of end user, the industry is divided into educational & research institutes, biopharmaceutical companies, contract development & manufacturing organizations and others end users.

By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Veterinary Vaccine Adjuvants Market to Reach USD 674.2 Million by 2034 rise at a CAGR of 4.6%, Driven by Rising Demand for Animal Health Solutions | FMI here

News-ID: 3839134 • Views:

More Releases from Future Market Insights Inc

Off-Highway EV Component Market to Explode to USD 130.9 Billion by 2035, Driven by Global Electrification Push
Off-Highway EV Component Market to Explode to USD 130.9 Billion by 2035, Driven …
The global Off-highway EV Component Market is poised for explosive growth, with a new market report forecasting its value to skyrocket from an estimated USD 37.9 billion in 2025 to a staggering USD 130.9 billion by 2035. This remarkable expansion represents a robust Compound Annual Growth Rate (CAGR) of 13.2% over the forecast period, fueled by stringent emission regulations, advancements in battery technology, and a global industry-wide shift toward sustainability
Global E-Bike Motors Market Set for Explosive Growth, Predicted to Quadruple to USD 31 Billion by 2035
Global E-Bike Motors Market Set for Explosive Growth, Predicted to Quadruple to …
The global E-Bike Motors Market is on track for a period of rapid expansion, fueled by the accelerating worldwide adoption of electric mobility and strong government backing for clean transportation. According to a new market analysis, the sector's valuation is projected to nearly quadruple over the next decade, growing from USD 8.4 billion in 2025 to a staggering USD 31 billion by 2035. This represents an impressive Compound Annual Growth
Acoustic Vehicle Alerting System (AVAS) Market Set to Quadruple, Driven by Safety Mandates and EV Boom
Acoustic Vehicle Alerting System (AVAS) Market Set to Quadruple, Driven by Safet …
The global market for Acoustic Vehicle Alerting Systems (AVAS), essential for enhancing pedestrian safety around silent electric and hybrid vehicles, is poised for explosive growth, according to a new market outlook report. The market, valued at USD 2.5 billion in 2025, is anticipated to reach a staggering USD 10.1 billion by 2035, expanding at a robust Compound Annual Growth Rate (CAGR) of 15%. This dramatic four-fold multiplication is a direct
Global Market Set for USD 14.9 Billion Valuation as OEMs Standardize Advanced Driver Assistance Systems (ADAS)
Global Market Set for USD 14.9 Billion Valuation as OEMs Standardize Advanced Dr …
The global market for Adaptive Cruise Control (ACC) and Blind Spot Detection (BSD) systems is poised for substantial growth, driven by stringent safety regulations and escalating consumer demand for advanced driver assistance systems (ADAS). A new market outlook report projects the market, estimated at USD 6.9 billion in 2025, will surge to USD 14.9 billion by 2035, exhibiting a robust Compound Annual Growth Rate (CAGR) of 7.8% over the decade. Dive

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion